S. D. Khoiriyah, Neily Zakiyah, Auliya A. Suwantika
{"title":"Analisis Efektivitas Biaya Penggunaan Kontrasepsi di Indonesia Tahun 2014–2017","authors":"S. D. Khoiriyah, Neily Zakiyah, Auliya A. Suwantika","doi":"10.15416/ijcp.2019.8.3.188","DOIUrl":"https://doi.org/10.15416/ijcp.2019.8.3.188","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115366207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Catharina A. W. Heryanto, Claudia S. F. Korangbuku, Maria I. A. Djeen, Aris Widayati
{"title":"Pengembangan dan Validasi Kuesioner untuk Mengukur Penggunaan Internet dan Media Sosial dalam Pelayanan Kefarmasian","authors":"Catharina A. W. Heryanto, Claudia S. F. Korangbuku, Maria I. A. Djeen, Aris Widayati","doi":"10.15416/ijcp.2019.8.3.175","DOIUrl":"https://doi.org/10.15416/ijcp.2019.8.3.175","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117196485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lily Annisa, I. Pramantara, Arianti Arianti, Fita Rahmawati
{"title":"Hubungan Penggunaan Obat Psikoaktif dengan Risiko Jatuh pada Pasien Geriatri di Klinik Penyakit Dalam Rumah Sakit di Madiun","authors":"Lily Annisa, I. Pramantara, Arianti Arianti, Fita Rahmawati","doi":"10.15416/ijcp.2019.8.3.217","DOIUrl":"https://doi.org/10.15416/ijcp.2019.8.3.217","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116227447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Verra Yuliana, Anton Setiadi, Yosephine P. Ayuningtyas
{"title":"Efek Konseling Apoteker Terhadap Kepatuhan Minum Obat dan Kualitas Hidup Penderita Skizofrenia di Rumah Sakit Jiwa Menur Surabaya","authors":"Verra Yuliana, Anton Setiadi, Yosephine P. Ayuningtyas","doi":"10.15416/ijcp.2019.8.3.196","DOIUrl":"https://doi.org/10.15416/ijcp.2019.8.3.196","url":null,"abstract":"Skizofrenia merupakan gangguan psikiatri yang kompleks ditandai dengan gangguan kognitif, \u0000emosi, persepsi, berpikir dan berperilaku. Penelitian ini dilakukan untuk mengetahui perbedaan \u0000tingkat kepatuhan minum obat pasien skizofrenia sebelum dan setelah diberikan konseling oleh \u0000apoteker serta untuk mengetahui kualitas hidupnya. Metode penelitian ini adalah one-grup \u0000pretest-posttest yang bersifat prospektif. Pengambilan sampel terhadap responden sesuai kriteria \u0000inklusi dilakukan di Instalasi Farmasi Rumah Sakit Jiwa Menur pada bulan Mei sampai Juli \u0000tahun 2018. Sebelum pengambilan data dilakukan, responden yang sesuai dengan kriteria inklusi \u0000diberikan penjelasan tentang tujuan dan gambaran penelitian. Apabila setuju menjadi subjek, \u0000pasien atau keluarganya diwajibkan mengisi informed consent. Wawancara sesuai kuesioner \u0000Medication Adherence Rating Score (MARS) dan The World Health Organization Quality of \u0000Life (WHOQOL)-BREF pada responden dilakukan dua kali, yakni pada kedatangan pertama \u0000sebelum dilakukan konseling dan satu bulan kemudian saat subjek kontrol kembali. Total \u0000responden sebanyak 100 orang. Data dianalisis menggunakan uji beda (uji T). Hasil penelitian \u0000menunjukkan terdapat perbedaan bermakna pada kepatuhan minum obat responden antara prepost \u0000konseling oleh apoteker (p=0,033). Hasil penelitian ini menunjukkan bahwa kualitas hidup \u0000subjek memiliki perbedaan bermakna hanya terkait domain lingkungan (p=0,00), sedangkan \u0000pada domain fisik, mental dan sosial tidak memiliki perbedaan bermakna (p>0,05).","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126562405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gilang S. Pramanik, I. M. Puspitasari, Cherry Rahayu, Auliya A. Suwantika
{"title":"Analisis Tingkat Kepuasan Pasien Rawat Inap Diabetes Melitus Tipe 2 dengan Komplikasi Ginjal di Fasilitas Kesehatan Tingkat Lanjut","authors":"Gilang S. Pramanik, I. M. Puspitasari, Cherry Rahayu, Auliya A. Suwantika","doi":"10.15416/IJCP.2018.7.3.217","DOIUrl":"https://doi.org/10.15416/IJCP.2018.7.3.217","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114972714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hematologic Toxicities of Chemotherapy in Lung Cancer Patients: A Retrospective Study in Dr. M. Djamil Hospital Padang, Indonesia","authors":"Yori Yuliandra, Hansen Nasif, Sabrina Ermayanti, L. Sulistyowati, Dian Ayu Juwita","doi":"10.15416/IJCP.2019.8.2.129","DOIUrl":"https://doi.org/10.15416/IJCP.2019.8.2.129","url":null,"abstract":"The use of chemotherapeutic agents in the management of cancer is often followed by a range of toxicities to various organ systems. A retrospective study on the hematologic toxicities of chemotherapy in lung cancer patients has been carried out. The study was conducted by a cross-sectional method from medical records of four-year data in 2010–2014 at Dr. M. Djamil Hospital Padang, West Sumatra, Indonesia. Data from medical records of patients diagnosed with lung cancer and underwent chemotherapy, not suffering from primary hematologic diseases, and with normal kidney and liver function prior to chemotherapy were studied. A number of 22 medical records of lung cancer patients which met the criteria with a total of 40 chemotherapy cycles were observed. The study revealed that a combination of carboplatin-paclitaxel was the most common chemotherapy used for the patients (72.7%). The hematologic toxicities comprised anemia, leukopenia, and thrombocytopenia with the severity ranging from grade 1–3. Carboplatin-paclitaxel was the only combination that caused these three toxicities, and the only combination to cause thrombocytopenia as well. Anemia was the major hematologic toxicity experienced by more than half of the patients. The study concludes that there is a reasonably high incidence of hematologic toxicities from chemotherapy among lung cancer patients.Keywords: Anemia, chemotherapy, hematologic toxicity, leukopenia, lung cancer, thrombocytopenia Toksisitas Hematologis Akibat Kemoterapi pada Pasien Kanker Paru: Studi Retrospektif di RSUP Dr. M. Djamil PadangAbstrak Penggunaan obat kemoterapi dalam pengobatan kanker sering disertai dengan toksisitas pada beberapa sistem organ. Kajian retrospektif terhadap toksisitas hematologis akibat kemoterapi pada pasien kanker paru sudah dilaksanakan. Studi ini dilaksanakan dengan metode cross-sectional dari data rekam tahun 2010–2014 di RSUP Dr. M. Djamil Padang, Sumatera Barat. Data pasien yang didiagnosis menderita kanker paru yang menjalani kemoterapi, tidak menderita penyakit hematologis dan gangguan hematopoiesis, serta memiliki fungsi ginjal dan hati yang normal dimasukkan ke dalam kajian. Sejumlah 22 pasien memenuhi kriteria dengan jumlah siklus kemoterapi sebanyak 40. Hasil kajian ini mengungkap bahwa kombinasi karboplatin-paklitaksel merupakan kemoterapi yang paling banyak digunakan (72,2%). Toksisitas hematologis yang terjadi meliputi anemia, leukopenia, dan trombositopenia dengan tingkat keparahan 1–3. Karboplatin-paklitaksel merupakan satu-satunya kombinasi kemoterapi yang menyebabkan ketiga toksisitas hematologis tersebut, sekaligus juga merupakan satu-satunya kombinasi yang menimbulkan trombositopenia. Anemia merupakan toksisitas hematologis yang paling banyak terjadi meliputi lebih dari separuh pasien. Penelitian ini menyimpulkan bahwa terdapat toksisitas hematologis yang cukup tinggi akibat kemoterapi pada pasien kanker paru.Kata kunci: Anemia, kanker paru, kemoterapi, leukopenia, toksisitas h","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"96 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114502692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Setiawan, Yosi Irawati Wibowo, Adji Prayitno Setiadi, Yul'aini Nurpatria, Hernycane Sosilya, D. K. Wardhani, Menino O. Cotta, Mohd-Hafiz Abdul-Aziz, Jason A. Roberts
{"title":"Implementasi Antimicrobial Stewardship Program di Kawasan Asia: Sebuah Kajian Sistematis","authors":"E. Setiawan, Yosi Irawati Wibowo, Adji Prayitno Setiadi, Yul'aini Nurpatria, Hernycane Sosilya, D. K. Wardhani, Menino O. Cotta, Mohd-Hafiz Abdul-Aziz, Jason A. Roberts","doi":"10.15416/IJCP.2019.8.2.141","DOIUrl":"https://doi.org/10.15416/IJCP.2019.8.2.141","url":null,"abstract":"Antimicrobial Stewardship Program (ASP) is one of the recommended programs to optimize the prudent use of antimicrobials, particularly in the hospital settings. The successful ASP implementation is determined by numerous factors, including communication among healthcare workers, and the availability of human resources and facilities. There is limited evidence available regarding the ASP implementation in Asia, particularly in the low- and lower-middle income countries. This systematic review aimed to identify the type of ASP interventions implemented in Asian countries according to the income status and to describe the impact of ASP implementation on the clinical, microbiological, and financial outcomes. The search strategy was undertaken using PUBMED, and the search terms were “antimicrobial stewardship” and “Asia” which were combined with the use of a Boolean operator “AND”. In total, 28 articles from nine countries were included in the final review. No article from Indonesia could be found in this systematic review. There was only an article from a lower-middle income country that was conducted in a tertiary health institution. Most of the articles (22 articles) were from high-middle income countries and 18 of them were conducted either in the tertiary care or university affiliated hospitals. Prospective audit with intervention and feedback was the most frequent ASP used in which positive outcomes on the clinical, microbiological, and financial outcomes have been evidenced. The positive impact of ASP implementation should suggest the needs to initiate the program in the healthcare facilities in Indonesia while taking into account the available resources and the local cultures.","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133578252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of Effects of The Hypoglycemia Management Protocol with 40% Dextrose Concentrated Solution to the Post-Correction Blood Sugar Response through Intravenous Infusion and Intravenous Bolus","authors":"Yuriani Yuriani, R. Andrajati, L. A. Pramono","doi":"10.15416/IJCP.2019.8.2.99","DOIUrl":"https://doi.org/10.15416/IJCP.2019.8.2.99","url":null,"abstract":"Hypoglycemic patients who receive 40% dextrose (D40%) concentrated solution in the correction process need to avoid excessive blood glucose spikes. Administration of D40% was found in two different ways, through intravenous infusion (iv infusion) and intravenous bolus (iv bolus) and the effects of both types of administration were unknown. The purpose of this study was to compare the effect of a hypoglycemia treatment protocol using D40% concentrated solution to the post-correction blood sugar response through iv infusion and iv bolus at two different hospitals with two distinct protocols. This comparative analytical cross-sectional study was conducted retrospectively at St. Carolus Hospital (D40% iv infusion group) and Bella Hospital (D40% iv bolus group). Blood glucose responses, in form of coefficient of variation and degree of overcorrection, were compared between groups. The overall median blood glucose response was 69.5 (3–195) mg/dL for iv infusion group (n=60) and 77 (15–249) mg/dL for iv bolus group (n=62) (p=0.259). The coefficient of variation with iv infusion and iv bolus group were 47.18% and 52.75%, respectively. The median of degree of overcorrection in iv infusion group was lower compared with iv bolus group, 10% (0–138%) versus 23% (0–195%), respectively. Both D40% protocols did not have a significant correlation with the degree of overcorrection (Mann-Whitney test; p=0.099). D40% iv infusion and bolus administration had no effect to the post-correction blood sugar response.Keywords: Blood glucose, dextrose 40%, hypoglycemia, intravenous bolus, intravenous infusion Perbandingan Efek Protokol Manajemen Hipoglikemia dengan Larutan Pekat Dekstrosa 40% secara Intravena Infus dan Intravena Bolus terhadap Respon Gula Darah PascakoreksiAbstrakPasien hipoglikemia yang menerima larutan pekat dekstrosa 40% (D40%) dalam proses koreksinya perlu menghindari lonjakan gula darah yang berlebih. Cara pemberian D40% diberikan dengan dua cara yang berbeda yaitu melalui intravena infus (iv infus) dan intravena bolus (iv bolus), dan efek dari kedua jenis pemberian tersebut belum diketahui. Tujuan dari penelitian ini adalah membandingkan efek protokol manajemen hipoglikemia dengan larutan pekat D40% secara iv infus dan iv bolus terhadap respon gula darah pascakoreksi di dua rumah sakit dengan protokol yang berbeda. Penelitian analitik komparatif secara potong lintang ini dilakukan secara retrospektif di RS St. Carolus (kelompok iv infus D40%) dan RS Bella (kelompok iv bolus D40%). Respon gula darah, dalam bentuk koefisien variasi dan derajat overkoreksi, dibandingkan antara kedua kelompok. Median kenaikan gula darah pada kelompok iv infus D40% 69,5 (3–195) mg/dL (n=60 pasien) dan kelompok iv bolus D40% 77 (15–249) mg/dL (n=62 pasien) (p=0,259). Koefisien variasi dengan iv infus adalah 47,18% dan iv bolus 52,75%. Median derajat overkoreksi iv infus D40% lebih rendah dibandingkan iv bolus D40%, dengan masing-masing 10% (0–138%) dan 23% (0–195%). Kedua c","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134524682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrew Citrawan, Oki Suwarsa, Hendra Gunawan, Sudigdo Adi, R. Lesmana, Achadiyani Achadiyani, Sunaryati S. Adi
{"title":"Pengaruh Krim Asam Traneksamat terhadap Pembentukan Keriput dan Kadar Matriks Metaloproteinase-1 pada Mencit (Mus Musculus) Jantan Galur Balb/c yang Dipajan Sinar Ultraviolet B","authors":"Andrew Citrawan, Oki Suwarsa, Hendra Gunawan, Sudigdo Adi, R. Lesmana, Achadiyani Achadiyani, Sunaryati S. Adi","doi":"10.15416/IJCP.2019.8.2.121","DOIUrl":"https://doi.org/10.15416/IJCP.2019.8.2.121","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114871596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laksmi Maharani, E. D. Utami, Ika Mustikaningtias, M. W. Suryoputri, Pugud Samodro
{"title":"Pengaruh Konversi Antibiotik Intravena ke Rute Per-oral terhadap Outcome Ekonomi, Klinis dan Humanis pada Pasien Rawat Inap","authors":"Laksmi Maharani, E. D. Utami, Ika Mustikaningtias, M. W. Suryoputri, Pugud Samodro","doi":"10.15416/IJCP.2019.8.2.81","DOIUrl":"https://doi.org/10.15416/IJCP.2019.8.2.81","url":null,"abstract":"","PeriodicalId":351729,"journal":{"name":"Indonesian Journal of Clinical Pharmacy","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133104016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}